Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





4 subtopics

 

  • Diphtheria-Tetanus-acellular Pertussis Vaccines
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Diphtheria-Tetanus Vaccine
  • Measles-Mumps-Rubella Vaccine

Vaccines, CombinedFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Complex Mixtures > Biological Products > Vaccines > Vaccines, Combined

Latest papers

[The effectiveness and safety of vaccine against meningococci group C conjugated with tetanus toxoid co-administrated with different vaccines--literature review].

Otitis media: viruses, bacteria, biofilms and vaccines.

Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine.

Efficacy of several vaccination programmes in commercial layer and broiler breeder hens against experimental challenge with Salmonella enterica serovar Enteritidis.

Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.

Future of polio vaccines.

Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.

A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

Innovative vaccine production technologies: the evolution and value of vaccine production technologies.

Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.

Vaccines and autism: a tale of shifting hypotheses.

Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.

Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population.

Compatibility of a combined vaccination against Haemophilus parasuis and porcine reproductive and respiratory syndrome virus.

[Recombinant heat-shock protein (rHSP70) boosts activation of innate and adaptive immunity during simultaneous administration with bacterial antigens in experiment].

Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses.

Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.

page 1 2 3 4 5 6 7 8 9 10 11 ...